To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Toxoplasma gondii calcium-dependent protein kinase 1 (CDPK1)

Infectious disease

INDICATION: Toxoplasmosis

In vitro and mouse studies identified a pyrazolopyrimidine-based inhibitor of Toxoplasma gondii

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE